VERGONI, Anna Valeria
 Distribuzione geografica
Continente #
NA - Nord America 5.289
EU - Europa 2.771
AS - Asia 1.588
SA - Sud America 267
AF - Africa 18
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 3
Totale 9.949
Nazione #
US - Stati Uniti d'America 5.260
GB - Regno Unito 1.300
SG - Singapore 488
CN - Cina 456
SE - Svezia 387
HK - Hong Kong 382
IT - Italia 276
BR - Brasile 238
DE - Germania 179
RU - Federazione Russa 162
UA - Ucraina 146
TR - Turchia 131
FI - Finlandia 114
BG - Bulgaria 59
FR - Francia 40
KR - Corea 28
LT - Lituania 27
BE - Belgio 18
NL - Olanda 15
IE - Irlanda 14
AU - Australia 13
CA - Canada 13
IN - India 13
RO - Romania 12
VN - Vietnam 12
MY - Malesia 10
AR - Argentina 9
ID - Indonesia 9
JP - Giappone 9
BD - Bangladesh 7
MX - Messico 7
EC - Ecuador 6
ZA - Sudafrica 6
AZ - Azerbaigian 5
CO - Colombia 5
IR - Iran 5
NP - Nepal 5
CL - Cile 4
HN - Honduras 4
IQ - Iraq 4
MA - Marocco 4
TW - Taiwan 4
CH - Svizzera 3
EG - Egitto 3
ES - Italia 3
PK - Pakistan 3
VE - Venezuela 3
AT - Austria 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EU - Europa 2
IL - Israele 2
JM - Giamaica 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
PL - Polonia 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
BT - Bhutan 1
DZ - Algeria 1
ET - Etiopia 1
GE - Georgia 1
GR - Grecia 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
PT - Portogallo 1
RS - Serbia 1
SA - Arabia Saudita 1
TH - Thailandia 1
TN - Tunisia 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 9.949
Città #
Southend 1.015
Santa Clara 708
Chandler 491
Fairfield 473
Woodbridge 399
Hong Kong 375
Jacksonville 326
Houston 296
Ann Arbor 294
Ashburn 283
Singapore 257
Nyköping 242
Dearborn 211
Seattle 207
Wilmington 173
Cambridge 166
London 133
Hefei 88
Modena 86
Beijing 84
Izmir 76
Princeton 63
Moscow 61
Sofia 58
Eugene 56
San Diego 53
Helsinki 52
Shanghai 45
Council Bluffs 37
New York 33
Redwood City 30
Bremen 27
Des Moines 27
Chicago 23
Seoul 23
Fremont 20
The Dalles 20
Falls Church 19
Los Angeles 19
Brussels 16
Milan 16
São Paulo 16
Boardman 15
Munich 15
Dublin 14
Norwalk 12
Nanjing 10
Rio de Janeiro 10
Guangzhou 9
Kunming 9
San Mateo 9
Sydney 9
Frankfurt am Main 8
Hounslow 8
Kilburn 8
Paris 8
Verona 8
Auburn Hills 7
Belo Horizonte 7
Central 7
Chiswick 7
Dallas 7
Indiana 7
Rome 7
Jakarta 6
Parma 6
Saint Petersburg 6
Turku 6
Baku 5
Columbus 5
La Spezia 5
Mountain View 5
Nanchang 5
Baoding 4
Brescia 4
Carmichael 4
Charlotte 4
Dong Ket 4
East Rutherford 4
Ferrara 4
Florence 4
Hangzhou 4
Ho Chi Minh City 4
Kathmandu 4
Leawood 4
Manaus 4
Naples 4
Ottawa 4
Philadelphia 4
Ribeirão Preto 4
Tokyo 4
Toronto 4
Boretto 3
Camerino 3
Chengdu 3
Fontanafredda 3
Goiânia 3
Hanoi 3
Las Vegas 3
Mexico City 3
Totale 7.447
Nome #
Can leptin-derived sequence-modified nanoparticles be suitable tools for brain delivery? 266
Targeting the Central Nervous System: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123 256
CCAP regulates feeding behavior via the NPF pathway in Drosophila adults 245
Peptide-engineered polylactide-co-glycolide (PLGA) nanoparticles for brain delivery of drugs: in vivo experiments and proof of concept 239
Nanoparticles as drug delivery agents specific for CNS: in vivo biodistribution 233
Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: In vivo pharmacological evidence and biodistribution 219
Similarities and differences between chronic migraine and episodic migraine 215
Glycopeptide-decorated nanoparticles as drug carriers for CNS: effects of surface coverage and carbohydrate type 214
Effect of acute and chronic treatment with triiodothyronine on serotonin levels and serotonergic receptor subtypes in the rat brain 210
Nanoparticles for brain delivery of drugs: in vivo experiments andmechanism of BBB crossing 202
Adhesion GPCRs are widely expressed throughout the subsections of the gastrointestinal tract 202
Anatomia chimica e funzionale dei sistemi peptidergici. 201
Health risk assessment of environmental selenium: Emerging evidence and challenges (Review) 201
Brain effects of melanocortins 200
Cholecystokinin peptides and bombesin reverse hemorrhagic shock in rats 195
Afferent vagal fibres and central cholinergic mechanisms are involved in the TRH-induced reversal of haemorrhagic shock 194
Nanoparticles for brain delivery of drugs: in vivo experiments and mechanism of BBB crossing 193
INFLUENCE OF ACTH-(1-24) ON INGESTIVE BEHAVIOURS 186
Streptozotocin-induced diabetes provokes changes in serotonin concentration and on 5-HT1A and 5-HT2 receptors in the rat brain 186
Oral delivery of insulin loaded into polymeric nanoparticles in rats. 185
Effect of repeated administration of prolactin releasing peptide on feeding behavior in rats 179
Effect of late treatment with gamma-hydroxybutyrate on the histological and behavioral consequences of transient brain ischemia in the rat. 175
BRAIN ACETYLCHOLINE IS INVOLVED IN THE ACTH-INDUCED BEHAVIORAL SYNDROME IN RATS 174
Characterization of the resistance to the anorectic and endocrine effects of leptin in obesity-prone and obesity-resistant rats fed a high-fat diet 174
New perspectives in peptides- and antibodies- conjugated nanocarriers for brain delivery therapeutic purposes 174
Brain MC4 receptors are involved in the melanocortin-induced hemorrhagic shock reversal, in rats 173
Influence of clonidine on the ACTH-induced behavioral syndrome 172
Putrescine has antiarrhythmic effects in rat models of arrhythmia. 171
Sistemi anti-analgesici endogeni 171
Engineered polylactide-co-glycolide(PLGA) Np as drug delivery systems for the Central Nervous System 170
Surface decorated nanoparticles as drug delivery agents to the brain 170
Polymeric nanoparticles for CNS drug delivery: strategies and perspectives 165
Evidence that melanocortin 4 receptor mediates hemorrhagic shock reversal caused by melanocortin peptides 162
Neuroprotective effect of L-DOPA co-administered with the adenosine A(2A) receptor agonist CGS 21680 in an animal model of Parkinson's disease 158
Energy gradients for VT-signal migration in the CNS: studies on melanocortin receptors, mitochondrial uncoupling proteins and food intake 157
Modified PLGA Nanoparticles as drug carriers for CNS delivery 155
Effetti periferici degli oppioidi 154
Mechanism of action of the anti-shock effect of CCK-8: influence of CCK antagonists and of sympatholytic drugs 153
Receptor heteromerization in adenosine A2A receptor signaling: Relevance for striatal function and Parkinson's disease 153
Anti-shock effect of CCK-8 mechanis of action 152
Peptide-decorated nanoparticles as carriers for drug delivery to CNS 150
Leptin-conjugated nanoparticles as drug delivery system to the brain 150
Nanoparticelle polimeriche per il direzionamento di farmaci al Sistema Nervoso Centrale 149
Engineered nanoparticles for drug delivery to the CNS: in vivo experiments 149
Chronic treatment with polychlorinated biphenyls (PCB) during pregnancy and lactation in the rat: Part 2: Effects on reproductive parameters, on sex behavior, on memory retention and on hypothalamic expression of aromatase and 5alpha-reductases in the offspring 149
Anti-shock effect of ACTH-(1-24): comparison between intracerebroventricular and intravenous route of administration 149
NPY-induced inhibition of male copulatory acivity is a direct behavioural effect 148
Neuroprotective effect of gamma-hydroxybutyrate in transient global cerebral ischemia in the rat 148
Chronic i.c.v infusion either of a melanocortin agonist or of an antagonist at low doses profoundly modifies energy balance without any other behavioral effects, in rats 147
Functional role, structure, and evolution of the melanocortin-4 receptor 147
Peptide-derivatized nanoparticles as carriers of drugs into the central nervous system 144
A 7-DAY I.V.C. INFUSION OF ACTH-(1-24), IN RATS, IS ASSOCIATED WITH THE DEVELOPMENT OF TOLERANCE TO ITS BEHAVIOURAL EFFECTS AND WITH INCREASED LEVELS OF HYPOTHALAMIC B-ENDORPHIN 140
Evidence that melanocortins are physiological antagonists of opioids 139
Endogenous antagonists of opioid peptides 135
Regulation of hypothalamic endocannabinoid levels by neuropeptides and hormons involved in food intake and metabolism: insulin and melanocortins 127
Nanoparticles and Brain Targeting 115
Differential influence of a selective melanocortin MC4 receptor antagonist (HS014) on melanocortin-induced behavioral effects in rats 64
Inhibition of feeding by ACTH-(1-24): behavioral and pharmacological aspects 61
LACK OF INFLUENCE OF AROMATASE AND 5-ALPHA-REDUCTASE INHIBITION ON [H-3] IMIPRAMINE BINDING IN THE MALE-RAT BRAIN 3
PINACIDIL POTENTIATES MORPHINE ANALGESIA 2
l-Sulpiride, at a low, non neuroleptic dose, prevents conditioned fear stress induced freezing behavior in rats 2
OPENING OF BRAIN POTASSIUM-CHANNELS INHIBITS THE ACTH-INDUCED BEHAVIORAL SYNDROME IN THE MALE-RAT 1
REPEATED ADMINISTRATION OF TRIIODOTHYRONINE ENHANCES THE SUSCEPTIBILITY OF RATS TO ISONIAZID-INDUCED AND PICROTOXIN-INDUCED SEIZURES 1
EFFECTS OF THYROID STATUS ON THE CHARACTERISTICS OF ALPHA1-IMIPRAMINE, ALPHA2-IMIPRAMINE, BETA-IMIPRAMINE IMIPRAMINE AND GABA RECEPTORS IN THE RAT-BRAIN 1
INFLUENCE OF GONADOTROPIN-RELEASING-HORMONE ON CASTRATION-INDUCED DEPRESSION IN MICE - A BEHAVIORAL AND BINDING STUDY 1
INFLUENCE OF THE SELECTIVE CHOLECYSTOKININ ANTAGONIST L-364,718 ON PAIN THRESHOLD AND MORPHINE ANALGESIA 1
NO MODIFICATIONS OF GABA(A) AND BENZODIAZEPINE RECEPTORS FOLLOWING EXPERIMENTAL DYSTHYROIDISM IN RATS 1
Corticotropin-releasing factor (CRF) induced anorexia is not influenced by a melanocortin 4 receptor blockage. 1
Behavioral effects of atriopeptin in rats. 1
Melanocortins and feeding behavior 1
CHRONIC ADMINISTRATION OF I-SULPIRIDE AT NON-NEUROLEPTIC DOSES REDUCES THE DURATION OF IMMOBILITY IN EXPERIMENTAL-MODELS OF DEPRESSION-LIKE BEHAVIOR 1
Totale 9.982
Categoria #
all - tutte 43.070
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.070


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202084 0 0 0 0 0 0 0 0 0 0 0 84
2020/20211.278 126 78 121 106 124 52 111 171 86 190 73 40
2021/2022983 27 141 86 73 29 45 49 34 107 57 212 123
2022/20231.215 159 164 84 128 150 193 24 96 130 9 37 41
2023/2024666 25 42 52 44 139 50 85 83 23 15 63 45
2024/20252.605 92 20 42 184 526 360 276 150 270 95 278 312
Totale 9.982